Sun Pharma launches LEQSELVI™ in the U.S. after patent settlement with Incyte
Sun Pharmaceutical Industries Limited announced the official launch of LEQSELVI (deuruxolitinib tablets 8 mg) in the United States for the treatment of adults with severe alopecia areata